Physician profile
Jules A Walters, II
NPI 1972793479
$40,924.34
in general payments reported to CMS, 2019-2025
17 companies · $5,609 in 2025
The $5,609 reported for 2025 was more than what 91% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,253 · 2020: $375 · 2021: $2,751 · 2022: $1,941 · 2023: $21K · 2024: $6,529 · 2025: $5,609.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $16K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $6,366 · Consulting Fee: $4,400 · Food and Beverage: $3,683 · Travel and Lodging: $3,206.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $15,950.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $6,365.90 |
| Consulting Fee | $4,400.00 |
| Food and Beverage | $3,682.94 |
| Travel and Lodging | $3,205.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Solta Medical, A Division of Bausch Health US, LLC | $24,824.39 | 2021-2025 | Clear+Brilliant |
| Abbvie INC. | $8,431.61 | 2022-2025 | Alloderm, Botox, Natrelle Saline-Filled Breast Implants |
| Allergan, INC. | $4,779.88 | 2019-2023 | |
| Axogen | $648.42 | 2019-2022 | |
| Davol INC. | $596.14 | 2022-2025 | |
| Integra Lifesciences Corporation | $425.12 | 2023-2025 | Integra, Surgimend, Omnigraft |
| Tepha INC | $288.81 | 2019 | |
| Galderma Laboratories, L.P. | $213.94 | 2019-2025 | Dysport |
| Avita Medical Americas, LLC | $149.89 | 2025 | Cohealyx, Permeaderm, Recell |
| Smith+Nephew, INC. | $145.72 | 2019 | |
| Musculoskeletal Transplant Foundation INC. | $142.59 | 2021 | |
| Motiva USA, LLC | $100.71 | 2024-2025 | |
| Sientra, INC. | $77.38 | 2019-2021 | |
| Mentor Worldwide LLC | $44.69 | 2019 | |
| Revance Therapeutics, INC. | $20.51 | 2025 | Daxxify |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertex Pharmaceuticals Incorporated | $18.13 | 2025 | |
| Pacira Pharmaceuticals Incorporated | $16.41 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jules Walters listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.